Bristol Myers CEO says America’s biopharma pole position is not guaranteed

NEW YORK — Bristol Myers Squibb CEO Chris Boerner said America’s role as the global biopharma leader is at a “pivot point” as the Trump administration aims to remake the country’s institutions and Chinese innovation is ...

Related Posts

Lilly says further head-to-head trial data back Zepboun...

May 12, 2025  0

CRISPR isn’t living up to its potential. Two scientists...

May 8, 2025  0

Pharmacy Empower allegedly used low-quality ingredients...

May 15, 2025  0

Comments

Name

Email

Comment

Post Comment